Search

everythinglearnresearchcommunity

for

Search:↓

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

People with alopecia areata have higher insulin resistance.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Hydroxychloroquine may help treat alopecia areata in children.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Researchers developed an algorithm for self-diagnosing scalp conditions with high accuracy using smart device-attached microscopes.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

UV light causes skin color loss in bald areas; wear a cap and use sunscreen.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.